Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits
Journal of Law, Medicine & Ethics · 2023
DOI: 10.1017/jme.2024.12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Law, Medicine & Ethics, 2023. Verfasst von Erica N White und 3 weiteren Autor:innen. Beteiligte Einrichtung: SANDRA DAY O'CONNOR COLLEGE OF LAW, ARIZONA STATE UNIVERSITY, PHOENIX, ARIZONA, USA. Hauptthemen laut MEDLINE: Medicare, Prescription Drugs. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
A series of structural constitutional arguments lodged in multiple cases against Centers for Medicare and Medicaid Services’ (CMS) authorities to negotiate prescription drug prices via the 2022 Inflation Reduction Act threaten the legitimacy of CMS program and federal agency powers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- SANDRA DAY O'CONNOR COLLEGE OF LAW, ARIZONA STATE UNIVERSITY, PHOENIX, ARIZONA, USA.
Zitieren
APA
White, E. N., Saxon, M., Hodge, J. G., & Michaels, J. (2023). Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits. Journal of Law, Medicine & Ethics. https://doi.org/10.1017/jme.2024.12
Vancouver
White EN, Saxon M, Hodge JG, Michaels J. Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits. Journal of Law, Medicine & Ethics. 2023. doi:10.1017/jme.2024.12
BibTeX
@article{White2023,
author = {White, Erica N and Saxon, Mary and Hodge, James G and Michaels, Joel},
title = {Medicare Drug Pricing Negotiations: Assessing Constitutional Structural Limits},
journal = {Journal of Law, Medicine & Ethics},
year = {2023},
doi = {10.1017/jme.2024.12}
}
EUVIMED